NEW YORK, Dec. 3 (GenomeWeb News) - CeMines has created a new operating division in Estonia called CeMines International, which will become a wholly owned subsidiary of CeMines, the company said today.
In Estonia, CeMines will "expand [its] research-and-development initiatives, establish a regulatory-affairs presence in the European Union and accelerate commercialization of new methods and technology," according to CEO Roger Attick.
"A comprehensive international business strategy is central to long-term competitive advantages," Attick added. CeMines will also leverage its presence in Europeto cultivate new research partnerships and distribution channels."
CeMines, based in Golden, Colo., is developing its molecular fingerprinting technologies for early-stage diagnostics and therapeutics.